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Abstract
Objectives—Extracellular nucleotide release at the site of arterial injury mediates proliferation 
and migration of vascular smooth muscle cells (SMC). Our aim was to investigate the role of the 
P2Y2 nucleotide receptor (P2Y2R) in neointimal hyperplasia.
Approach and Results—Vascular injury was induced by implantation of a polyethylene cuff 
around the femoral artery in wild-type and P2Y2 receptor-deficient mice (P2Y2R−/−). Electron 
microscopy was used to analyze monocyte and lymphocyte influx to the intima 36 hours post-
injury. Compared to wild-type (WT) littermates, P2Y2R−/− mice exhibited a 3-fold decreased 
number of mononuclear leukocytes invading the intima (p<0.05). Concomitantly, migration of 
smooth muscle cells was decreased by more than 60% (p<0.05) a resulting in a sharp inhibition of 
intimal thickening formation in P2Y2R−/− mice (n=15) 14 days after cuff placement. In vitro, loss 
of P2Y2 receptor significantly impaired monocyte migration in response to nucleotide agonists. 
Furthermore, transgenic rats over-expressing the P2Y2R developed accelerated intimal lesions 
resulting in more than 95% luminal stenosis (P<0.05, n=10).
Conclusions—Loss-and gain-of-function approaches established a direct evidence for P2Y2 
receptor involvement in neointimal hyperplasia. Specific anti-P2Y2 receptor therapies may be used 
against restenosis and bypass graft failure.
Introduction
Neointimal hyperplasia is a key feature of early atherosclerosis and restenosis after 
angioplasty.1-2 Migration and proliferation of vascular smooth muscle cells (SMC) caused 
by injury are the underlying causes of intimal hyperplasia.3 In experimental intimal 
hyperplasia, an influx of leukocytes precedes the migration of SMC to the intima.4 Studies 
have shown that blockade of mononuclear leukocyte influx but not that of 
polymorphonuclear leukocytes prevent intimal accumulation of SMC in the collar model of 
injury4-5, thus excluding neutrophils as initiators of the migration of SMC into the intima. 
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Mononuclear cells have been shown to induce cytokine expression, vascular SMC 
proliferation, and arterial occlusion after endothelial injury.6 Increases in tumor necrosis 
factor (TNF)-α levels precede migration of SMC into the intima in the balloon-injured rat 
aorta.7 A more direct evidence for TNF-α involvement in intimal hyperplasia has been also 
established.8
Similar to cytokines, alterations in extracellular nucleotide concentrations in response to 
vascular stress conditions have been documented. Extracellular nucleotides are released in 
the vascular wall from perivascular nerves, activated platelets, and mechanically stretched 
cells.9-12 Extracellular nucleotides induce both proliferation and migration of vascular 
SMC.13-19 Mice deficient in CD39, the ectoenzyme which is mainly responsible for 
nucleotides degradation in vascular SMC, exhibit reduced intimal thickening in response to 
vascular injury.20 Up-regulation and activation of the P2Y2 receptor subtype has been shown 
to stimulate neointimal growth in the collared rabbit carotid artery.21 In this model, local 
UTP delivery induced intimal accumulation of monocytes. In addition, nucleotide binding to 
P2Y2 receptor stimulates the expression of vascular cell adhesion molecule-1, which 
suggests a role for UTP in early of leukocyte infiltration during vascular injury. However, the 
contribution of extracellular nucleotides and their receptors to intimal hyperplasia is still 
unclear.
Our aim was to establish a cause and effect relationship with respect to P2Y2 receptor 
activation and neointimal hyperplasia. We used loss-and gain-of-function approaches to 
show that P2Y2 receptor regulates early mononuclear lymphocyte influx to the intima in the 
cuff model of femoral artery injury. We demonstrated that mice lacking P2Y2 receptor 
develop less neointimal area following arterial injury, whereas over-expression of P2Y2 
receptor led to the formation of accelerated intimal thickening in rats. These data 
unequivocally provide direct evidence for P2Y2 receptor involvement in neointimal 
hyperplasia setting the stage for anti-P2Y2 receptor therapies against graft failure and post-
angioplasty restenosis.
Methods
Animals
Eight week-old wild-type and transgenic rats (Sprague-Dawley; Harlan, Indianapolis, IN) 
were used in this study. Transgenic rats over-expressing the P2Y2 receptor were produced as 
previously described using a lentiviral vector system and bred for 10 generations to ensure 
stability of the transgene.22 Wild-type and P2Y2R−/− mice (C57BL/6) were purchased from 
Jackson laboratory and used at 8 weeks of age. Animal protocols were approved by the 
University of Missouri Animal Care and Use Committee.
Femoral artery cuff placement
Animals were anesthetized with ketamine (70 mg/kg) and xylazine (4 mg/kg) by 
intraperitoneal injection. The right femoral artery of the mouse was isolated from the 
surrounding tissues. A polyethylene cuff made of PE-50 tubing (inner diameter, 0.56 mm; 
outer diameter, 0.965 mm; Becton Dickinson, Mountain View, CA) was cut longitudinally to 
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open the tube, loosely placed around the artery and closed with suture. The cuff is larger 
than the vessel, therefore blood flow was not obstructed. After the experimental period, the 
mice were killed by an overdose of the anesthesia. The cuffed artery was removed and 
micro-dissected from the cuff.
Tissue harvesting and histologic staining
After sacrifice, femoral arteries were fixed in situ by constant pressure fixation at 100 
mmHg with 10% formalin using a 22-gauge butterfly catheter placed in the left ventricle of 
the heart. Cuffed and sham-operated femoral arteries were then embedded in paraffin. Cross-
sections (5μM thin) were continuously cut from one edge to the other edge of the cuffed and 
the control femoral artery and mounted in order on five series of slides. Cross sections were 
then stained with elastica van Gieson, hematoxylin and eosin or used for 
immunohistochemistry.
Morphometry
Hematoxylin and eosin–stained cross sections were used for morphometric analysis. For this 
purpose, serial cross-sections (5 μm thick) were obtained every 75 μm throughout the entire 
length of the cuffed mouse femoral artery. To quantify intimal thickening, 5 equally spaced 
cross-sections in each animal were photographed, and the images were digitized. The areas 
of the neointima, the media, and the adventitia were measured using an image analyzing 
software (NIH image) by an observer blinded as to the animal genotype or the treatment. 
Neointima was defined as the area between the vessel lumen and the internal elastic lamina. 
Media was defined as the area between the internal and external elastic lamina. Adventitia 
was defined as the area outside the external elastic lamina.
Incorporation and detection of 5-bromo-2′-deoxyuridine (BrdU)
Mice were injected intraperitoneally with BrdU (25mg/kg; Sigma) 3, 2, and 1 day before 
euthanasia. Immunohistochemistry was performed using anti-BrdU antibody following the 
manufacturer's instructions (Zymed Laboratories). The number of BrdU-positive nuclei were 
counted in 5 cross-sections and expressed as a percentage of the total number of nuclei.
Electron microscopy
Femoral arteries were removed from the cuff at the end of the experimental period and 
processed for transmission electron microscopy as previously described. 5 Ultrathin sections 
were collected on 75-mesh copper grids, stained with lead citrate, and examined with a Zeiss 
EM 10. Intimal cells (monocytes, lymphocytes, neutrophils, basophils, and eosinophils and 
smooth muscle cells were identified on the basis of their ultrastructural features as 
previously reported.5 The number of intimal cells beneath the endothelium were determined 
for each cell type and expressed in relation to the number of endothelial cells overlying the 
lesion as previously described.5
Monocyte migration assay
Monocytes were is isolated from mouse blood using the EasySep™ mouse monocyte 
enrichment kit (StemCell Technologies) according to the manufacturer's instructions. Cell 
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migration assay was performed in a 48-well chemotaxis chamber (Neuro Probe Inc, 
Bethesda, MD) using polyvinylpyrrolidone-free polycarbonate filters with 5-μm diameter 
pores. The lower chamber contained RPMI 1640 medium, in the presence or absence 
(negative control) of stimulus, and the upper chamber contained the cell suspension (2 × 106 
cells/ml). The chemoattractant peptide N-formyl-methionylleucyl-phenylalanine (fMLP) 
served as positive control. The chamber was incubated at for 1 hour at 37 °C in air 
containing 5% CO2. At the end of the experiment, cells that have migrated were stained with 
hematoxylin. The number of migrated cells was determined after subtracting non-specific 
migration (negative control).
Statistical analyses
Data are presented as mean ± SEM. Statistical analysis was performed with Graphpad Prism 
using either two-tailed unpaired Student's t-test or one-way analysis of variance (ANOVA) 
followed by post hoc comparison. Differences with P values <0.05 were considered 
significant.
Results
P2Y2 receptor-deficiency reduces neointimal hyperplasia
To establish a cause-effect link between P2Y2R and intimal hyperplasia, we subjected wild-
type (n=15) and P2Y2R−/− mice (n=15) to cuff-induced injury of the femoral artery. We 
examined intimal lesion formation 14 days after injury, the time corresponding to a peak 
SMC accumulation of SMC. Figure 1A shows representative cross sections of the cuffed 
femoral arteries. Neointimal hyperplasia was uniformly distributed across the arterial lumen. 
P2Y2R−/− mice developed 7-fold less neointimal area than corresponding WT littermates 
(Figure 1B). Sham-operated arteries did not exhibit neointimal thickening (Figure 1B). 
Comparison of intima-to-media ratios confirmed the reduction in neointimal size observed 
in P2Y2R−/− mice (Figure 1C). The mean percent luminal stenosis was significantly higher 
in WT compared to P2Y2R−/− mice (Figure 1D). Cell proliferation as assessed by BrdU 
incorporation into SMC 4 days after cuff placement was significantly suppressed in 
P2Y2R−/− mice (Figure 1E). Intimal thickening in both groups were mainly composed of 
SM actin-positive cells (Figure 1F).
P2Y2 receptor deletion inhibits mononuclear lymphocyte influx to the intima
Mononuclear leukocytes (monocytes and lymphocytes) not neutrophils mediate the 
subsequent migration of medial SMC to the intima following arterial injury.4-5 We next 
asked if deletion of the P2Y2 receptor affects the influx of mononuclear leukocytes to artery 
following arterial injury. Electron microscopy has been used to distinguish granulocytes, 
(i.e., neutrophils, basophils, and eosinophils) from monocytes and lymphocytes by their 
specific granules.5 Because this method cannot always sharply distinguish between 
monocytes and lymphocytes, we therefore grouped lymphocytes and monocytes as 
mononuclear leukocytes as previously done.5 In WT mice, a significant number of 
mononuclear lymphocytes invaded the nascent intimal thickening 36h following cuff 
implantation (Figure 2A). Notably, mononuclear lymphocytes influx after cuff placement 
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was significantly suppressed in P2Y2R−/− mice (Figure 2A). These data clearly show that 
absence of P2Y2R blocks the influx of monocytes and lymphocytes during arterial injury.
Loss of P2Y2 receptor inhibits smooth muscle cell migration
As previously reported in the cuff model of injury, SMC migration is the dominant factor 
contributing to early accumulation of SMC in the nascent intima.4 We and others have 
shown that extracellular nucleotides acting through P2Y2R regulate SMC migration.18-19, 23 
Therefore, we asked if deletion of P2Y2R influences the migration of medial SMC to the 
intima. We identified SMC on the basis of their ultrastructural features using electron 
microscopy, and determined their number by quantitative analysis of ultrathin sections. SMC 
started to migrate from the underlying media into the intimal compartment 36h following 
cuff implantation. At this time point, the number of SMC that invaded the intima in 
P2Y2R−/− mice was strikingly lower as compared to wild-type littermates (Figure 2B). In 
contrast, no SMC was detectable in the intima in sham-operated arteries from either 
genotype (Figure 2B). These data demonstrate that loss of P2Y2R inhibits early migration of 
SMC to the intima.
Extracellular nucleotides acting through P2Y2 receptor promote monocyte migration
To elucidate the mechanism by which P2Y2R regulates mononuclear leukocyte influx, we 
tested whether P2Y2 receptor agonists promote monocyte migration. Using a chemotaxis 
assay, we found that UTPγS, a slowly hydrolysable analog of the P2Y2R promotes 
migration of monocyte from wild-type mice in a dose-dependent manner (Figure 3). In 
contrast, P2Y2 receptor deficiency significantly impaired monocyte migration in response to 
UTPγS (Figure). ATP, another potent agonist of P2Y2R also induced the migration of 
monocytes from WT but not from P2Y2R−/− mice (data not shown), confirming the 
involvement of P2Y2R in monocyte migration. As expected, monocyte migration in response 
to fMLP was similar between wild- type and P2Y2R−/− mice (Figure 3).
Over-expression of P2Y2R accelerates neointimal hyperplasia
We generated the first transgenic rat over-expressing a purinergic receptor.22 We next used 
this gain of function approach to test if over-expression of P2Y2R promotes neointimal 
hyperplasia. Wild- type and P2Y2R transgenic rats were subjected to femoral artery injury 
and intimal lesions were assessed at day 14. WT animals developed a modest intimal 
thickening (Figure 4A-B) consisting of α-SMC actin-positive cells (not shown). Rats over-
expressing the P2Y2R transgene exhibited a dramatic increase in neointimal area compared 
to WT littermates (Figure 4A-B), whereas sham-operated arteries did not exhibit intimal 
thickening (Figure 4B). There was no significant difference in the medial area between wild-
type and transgenic rats. As expected, the intima/media ratio was greater in the transgenic 
rats compared to wild-type controls (Figure 4C). The mean percent luminal stenosis in the 
transgenic rats was over 95% (p<0.001; Figure 4D), resulting in near blockade of the arterial 
lumen. These results further confirm that the P2Y2R is involved in neointimal hyperplasia.
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Discussion
Several lines of evidence support a role for extracellular nucleotides in the response to 
vascular injury. We first reported that P2Y2R is over-expressed in intimal lesions of the rat 
carotid artery.23 In addition, local delivery of nucleotides via a mini-osmotic pump to the 
collared rabbit carotid artery accelerates the development of intimal hyperplasia.21 
Furthermore, mice deficient in CD39 (the ectoenzyme which is mainly responsible for 
nucleotides degradation) exhibit reduced intimal thickening in response to vascular injury20, 
thus confirming the crucial role of extracellular nucleotides in the development of intimal 
hyperplasia. However, given that purinergic receptors are ubiquitously expressed in vascular 
cells, it was necessary to determine if the P2Y2R is directly involved in the vascular 
response to injury. In this study, we used loss-and gain-of-function approaches to directly 
assess the contribution of P2Y2R to neointimal hyperplasia. We demonstrated that P2Y2R 
deficiency decreased neointimal area induced by placement of a cuff around the mouse 
femoral artery. Conversely, over-expression of P2Y2R in rats accelerated neointimal 
hyperplasia resulting in near complete arterial luminal stenosis.
The P2Y2R is expressed in virtually all blood-derived cells.12 It was reported that blockade 
of mononuclear leukocyte influx but not that of neutrophils decreased intimal accumulation 
of SMC in the femoral artery cuff model of vascular injury4-5, thus excluding neutrophils as 
initiators of the migration of SMC into the intima. Activation of P2Y2R stimulates monocyte 
recruitment in the collared rabbit carotid artery.21 Mechanistically, we found that absence of 
P2Y2R significantly impaired mononuclear lymphocyte influx to the intima. In addition, 
monocyte lacking P2Y2R failed to migrate in response to nucleotide agonists, demonstrating 
the importance of monocyte P2Y2R in the early response to vascular injury. Stimulation of 
P2 receptors is coupled to the release of the pro-inflammatory cytokines interleukins24-27 
that are of obvious relevance to the development of neotimal hyperplasia. We showed that 
P2Y2R activation regulates the secretion of lymphotoxin-α (member of the TNF ligand 
family) in murine monocytes.28 Interestingly, ApoE−/− mice deficient in P2Y2R exhibit 
decreased production of lymphotoxin-α and delayed onset of atherosclerosis. Furthermore, 
administration of lymphotoxin-α neutralizing antibody also prevents lesion formation in 
ApoE−/− mice.29 These data suggest expressed in monocyte P2Y2R contributes to 
neointimal hyperplasia at least by modulating the secretion of cytokines that can directly 
influence SMC proliferation.
Ectoenzymes that metabolize ATP play important roles in regulating the response to 
endothelial dysfunction. In many cell types, including endothelial cells, nucleoside 
triphosphate diphosphohydrolase-1/CD39 and ecto-5'-nucleotidase/CD73 dephosphorylate 
ATP and ADP to AMP. AMP is then converted to adenosine by CD73 or other enzymes. The 
importance of this extracellular purinergic flux in controlling inflammation is apparent in 
mice genetically engineered to lack CD39.30-31 In these animals, activation of inflammatory 
cells such as platelets, macrophages, and neutrophils, and their adhesion to the vascular 
endothelium, are enhanced. Mice deficient in CD39, exhibit reduced intimal thickening in 
response to vascular injury.20 The P2Y2R is distinguished among G protein-coupled 
receptors in its ability to interact directly with growth factor receptors to transactivate their 
signal transduction pathways. For example, we have shown the importance of P2Y2R 
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interaction with vascular endothelial cell growth factor receptor (VEGFR-2) in the 
regulation of VCAM-1 expression.32 Since VCAM-1 plays a crucial role in both 
atherosclerosis and neointimal hyperplasia, targeted control of endothelial P2Y2R could 
prevent intimal hyperplasia that accompanies these processes.
Extracellular nucleotides acting via G protein-coupled P2Y2receptors serve as potent 
stimulators for migration SMC in vitro.18-19 Here, we demonstrated that P2Y2R deficiency 
prevent the early migration of SMC to the intima in response to cuff-induced injury. ATP 
stimulates release of matrix metalloproteinase-2 (MMP-2) from human aortic SMC33, and 
MMP-2-induced matrix degradation facilitates migration and proliferation of SMC.34 
Interestingly, both ATP and UTP are potent chemotactic agents that stimulate VSMC 
migration via P2Y2R.18-19 We have shown that P2Y2 receptor interacts with the actin-
binding protein filamin A to mediate SMC migration.35 Altogether, these mechanisms may 
explain our findings that perivascular infusion of UTP into the collared rabbit carotid arteries 
enhanced neointimal development21 and P2Y2R expression is associated with coronary in-
stent restenosis.36 Abundant sources for extracellular ATP in the vessel and the trophic 
effects on vascular SMC suggest that SMC P2Y2R might contribute to intimal hyperplasia 
by stimulating proliferation of vascular SMC. In support of this idea, a significant number of 
BrdU-positive SMC were detected in the cuffed artery of wild-type mice. In contrast, the 
percentage of proliferating cells was strikingly lower in P2Y2R−/− mice. Subsequently, we 
found that wild-type mice exhibited 7-fold more neointimal area compared to P2Y2R−/− 
mice. Furthermore, over-expression of the P2Y2 receptor drastically increased intimal 
hyperplasia causing a near complete blockade of the arterial lumen only 14 days after injury. 
Thus, we conclude that P2Y2R contributes to neointimal hyperplasia by stimulating both 
migration proliferation of vascular SMC. In summary, we demonstrated that P2Y2 receptor 
directly regulates the influx of mononuclear lymphocytes that are essential for subsequent 
migration and accumulation of SMC into the neointima. Therefore, this nucleotide receptor 
might be a therapeutic target for the prevention of graft failure and post-angioplasty 
restenosis.
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Figure 1. 
Morphometric analysis of cuffed femoral arteries in wild-type (WT) and P2Y2 receptor-
deficient (P2Y2R−/−) mice. A, representative images of hematoxylin-eosin staining of 
femoral arteries 14 days after cuff placement. Black arrows indicates internal elastic 
laminae, white and yellow arrows delineate the media and the intimal thickening, 
respectively. Scale bar represents 25μm. B, Cross-sectional intimal surface area of femoral 
arteries in WT and P2Y2R−/− mice. The intima to media ratio was measured in panel C and 
luminal stenosis (D) was calculated as the percentage of the area inside the internal elastic 
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lamina occupied by the intimal area (100 × IA/IELA). E, smooth muscle cell proliferation 
(% of BrdU-positive cells). Data are mean ± SEM. *P<0.05, one-way ANOVA with Tukey's 
multiple comparison post analysis. F, Immunohistochemical staining of smooth muscle α -
actin in injured femoral arteries from representative WT and P2Y2R−/− mice 14 days after 
cuff-induced injury. White and yellow arrows delineate the media and the intimal thickening, 
respectively. Scale bar represents 25μm.
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Figure 2. 
Intimal accumulation of mononuclear leukocytes and smooth muscle cells. Bar graph 
showing accumulation of mononuclear leukocytes (right) and smooth muscle cells (left) 
within the intimal lesion of WT and P2Y2R−/− mice. For quantitative analysis, ultrathin 
cross sections through the midregion of the cuff-bearing artery segment were selected from a 
minimum of four different planes separated by at least 0.1 mm as previously described.4 The 
number of intimal cells beneath the endothelium were determined for each cell type and 
expressed in relation in relation to 100 endothelial cells. Data are mean ± SEM. *P<0.05, 
one-way ANOVA with Tukey's multiple comparison post analysis.
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Figure 3. 
Monocyte migration in response to nucleotide stimulation. Migration assays were performed 
in modified Boyden chambers. Increasing concentrations of nucleotides were added to the 
lower well as indicated. The chemoattractant peptide fMLP was used as a positive control. 
Cell migration assay was performed in a 48-well chemotaxis chamber, and cells that have 
migrated were stained with hematoxylin. The number of migrated cells was determined after 
subtracting non-specific migration (negative control). Five independent experiments were 
performed. Data are mean ± SEM. *P<0.05, one-way ANOVA with Tukey's multiple 
comparison post analysis.
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Figure 4. 
Morphometric analysis of cuffed femoral arteries in wild-type and transgenic rats over-
expressing the P2Y2 receptor. A, representative images of hematoxylin eosin-stained cross 
section of injured femoral artery of WT and P2Y2R over-expressing rats 14 days after cuff 
placement. White and yellow arrows delineate the media and the intimal thickening, 
respectively. Scale bar represents 25μm. B, Cross-sectional intimal surface area of femoral 
arteries in WT and P2Y2R over-expressing rats. Quantitative computer-assisted image 
analysis of lesions was performed at day 14. Five μm-thick serial cross-sections were 
obtained every 100 μm throughout the entire length of the cuffed mouse femoral artery. To 
quantify neointimal area, 5 equally spaced cross-sections in each animal (n=10) were 
photographed, and the images were digitized. Intima/media ratio (C) and percentage of 
luminal stenosis (D) were calculated as described in Figure 1. Values are mean ± SEM. 
*P<0.05, one-way ANOVA with Tukey's multiple comparison post analysis.
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Figure 5. 
Schematic depicting the role of P2Y2 receptor in vascular response to injury. Mononuclear 
cells: ATP release during cuff-induced vascular injury activates P2Y2R in monocytic cells 
leading to cytokine secretion which in turn stimulates SMC migration and proliferation. 
Adenosine generated through degradation of ATP initiated by the ectoenzyme CD39 acts as 
inhibitor of SMC proliferation. Endothelial cells (EC): in endothelial cells, ATP acting 
through P2Y2R stimulates VCAM-1 expression via phosphorylation of VEGFR2 receptor. 
VCAM-1 which enables interaction between EC and monocytes plays a pivotal role in 
neointimal hyperplasia. Smooth muscle cells: P2Y2R activation in SMC mediates 
proliferation through ERK1/ERK2 and Phophosinositide 3-kinase (PI3-K) mechanisms. ATP 
acting on P2Y2R causes cytoskeleton rearrangement and matrix metalloproteinase (MMP-2) 
activation leading to SMC migration.
Agca et al. Page 15
J Vasc Res. Author manuscript; available in PMC 2017 October 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
